Citation Impact
Citing Papers
Let-7 Expression Is a Significant Determinant of Response to Chemotherapy through the Regulation of IL-6/STAT3 Pathway in Esophageal Squamous Cell Carcinoma
2012
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
2011 Standout
Global Cancer Incidence and Mortality Rates and Trends—An Update
2015 Standout
Value of complete metabolic response by 18F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy
2007
Space and the parietal cortex
2006 Standout
Gastric cancer
2016 Standout
Molecular imaging in drug development
2008 Standout
Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials
1995
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations
2003
Chemoradiotherapy of Locally Advanced Esophageal Cancer
1999 Standout
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus
2014
Resection for Esophageal Cancer: Strategies for Optimal Management
2008
The Functional Neuroanatomy of Target Detection: An fMRI Study of Visual and Auditory Oddball Tasks
1999
Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal Cancer
2006
Spectral versus visual EEG analysis in mild hepatic encephalopathy
1999
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
2005
Imaging in the era of molecular oncology
2008 StandoutNature
Nomograms in oncology: more than meets the eye
2015 Standout
Temporal Trends (1973–1997) in Survival of Patients With Esophageal Adenocarcinoma in The United States: A Glimmer of Hope?
2003
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
2007
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Esophageal Cancer
2003 Standout
Methods for Diagnosing Hepatic Encephalopathy in Patients with Cirrhosis: A Multidimensional Approach
2004
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer
2012
CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer
2001
Molecular mechanisms of cisplatin resistance
2011 Standout
American Gastroenterological Association Technical Review on the Role of the Gastroenterologist in the Management of Esophageal Carcinoma
2005
Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma
2001
The Reorienting System of the Human Brain: From Environment to Theory of Mind
2008 Standout
Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World
2001
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer
2002
Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus
1997
Curative Resection for Esophageal Adenocarcinoma
2001
Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization
2007
Oesophageal carcinoma
2013 Standout
Spectrum of neurocognitive impairment in cirrhosis
2009
Auditory P300 event‐related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: A follow‐up study
2001
Long-Term Results of a Phase II Trial of Neoadjuvant Chemotherapy Followed by Esophagectomy for Locally Advanced Esophageal Neoplasm
2008
Guidelines for the management of oesophageal and gastric cancer
2011
Radionuclide 131I labeled reduced graphene oxide for nuclear imaging guided combined radio- and photothermal therapy of cancer
2015
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy
2001
2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma
2004
Gastric cancer
2020 Standout
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
2013 Standout
Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis
2009
Critical flicker frequency: Diagnostic tool for minimal hepatic encephalopathy
2007
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer
1998
Saliency, switching, attention and control: a network model of insula function
2010 Standout
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
2008 Standout
Ivor Lewis esophagogastrectomy for esophageal cancer
2001
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
2007
Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma
2008
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Transhiatal Esophagectomy: Clinical Experience and Refinements
1999
Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer
2011
Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer
2004
Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998
2002 Standout
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.
1998
Biopsy-negative malignant esophageal stricture: diagnosis by endoscopic ultrasound
1998
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
Quantitative EEG analysis and evoked potentials to measure (latent) hepatic encephalopathy
1992
Esophageal cancer: results of an American College of Surgeons patient care evaluation study1
2000
Does Paclitaxel Improve the Chemoradiotherapy of Locoregionally Advanced Esophageal Cancer? A Nonrandomized Comparison With Fluorouracil-Based Therapy
2000
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial
2003
Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma
2001
Patients with ERCC1-Negative Locally Advanced Esophageal Cancers May Benefit from Preoperative Chemoradiotherapy
2008
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Surgical Management of Esophageal Carcinoma
1999
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
Adjuvant Chemotherapy for Resected Adenocarcinoma of the Esophagus, Gastro-Esophageal Junction, and Cardia: Phase II Trial (E8296) of the Eastern Cooperative Oncology Group
2004
Phase II Trial of Weekly Irinotecan Plus Cisplatin in Advanced Esophageal Cancer
1999
Recent advances in functional nanomaterials for light–triggered cancer therapy
2018
Management of Gastroesophageal Tumors
2007
Global cancer statistics, 2012
2015 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781
2008
Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
2009
Works of N. Keeling being referenced
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
1996 Standout
The auditory P300 event—related potential: An objective marker of the encephalopathy of chronic liver disease
1990